Please try another search
SINGAPORE - AstraZeneca PLC (LSE/STO/NASDAQ: LON:AZN), a global biopharmaceutical company, has announced plans to invest $1.5 billion in constructing a new manufacturing facility in Singapore...
SAN DIEGO - AstraZeneca (NASDAQ:AZN) is set to present new clinical and real-world data on its respiratory and immune-mediated disease treatments at the upcoming American Thoracic Society (ATS)...
LONDON - The European Commission has approved AstraZeneca (NASDAQ:AZN)'s Voydeya (danicopan) as an add-on treatment for adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who suffer from...
WASHINGTON D.C. - The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Enhertu for the treatment of adult patients with unresectable or metastatic HER2-positive solid tumors...
LONDON - AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo have received U.S. Food and Drug Administration (FDA) acceptance for a Biologics License Application (BLA) for their drug datopotamab deruxtecan...
TOKYO - AstraZeneca (NASDAQ:AZN), in partnership with Sanofi (EPA:SASY) (NASDAQ:SNY), has announced that its long-acting monoclonal antibody, Beyfortus (nirsevimab), has received approval from the...
TOKYO - AstraZeneca (NASDAQ:AZN)'s Truqap, in combination with Faslodex, has received approval in Japan for the treatment of certain advanced breast cancers, marking a significant advancement in the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review